In 2014, the founders of MM Genetics witnessed the therapeutic nature of cannabis whilst treating a founder’s mother. Candida Green was battling late stage pancreatic cancer. Hours after her first dose of cannabis oil her pain was greatly reduced and in the following weeks her quality of life dramatically improved.
The website medicalmarijuana.co.uk was set up shortly after her death with the simple aim of raising awareness of the true medicinal properties of the Cannabis Sativa L plant.
The benefits of the cannabis oil were clearly visible to those around her and awoke a passion and deep interest in the use of cannabis as a medicine. A concept to source and sell seeds with exciting therapeutic benefits was developed whilst raising awareness in local communities.
Through the organisation’s interaction with patients and cannabis communities worldwide, it quickly became apparent that the need was for cannabis genetics that targeted specific symptoms.
Medical Marijuana Genetics was formed in 2015 and began working with award winning breeders and caregivers. A line of CBD dominant cannabis strains has since been created and has gone on to win several awards including best CBD strain at Spannabis 2017. These CBD cannabis seeds are now available here.
The laboratory tests of our flagship strain, Candida, revealed a CBD count of 20% with a THC count of under 1%. This percentage is the highest known count in a CBD-rich phenotype ever created in Europe.
Following the overwhelming success of their first grow, Medical Marijuana Genetics created a further 12 elite strains from Candida crosses, all of which have been genetically selected to provide access (within lawful jurisdiction) to the widest range of therapeutics that the cannabis plant, and CBD in particular, has to offer. This includes treatments for symptoms such chronic pain, inflammation, seizures, convulsions, gastrointestinal disorders, nausea, vomiting, skin conditions, bacterial infections, anxiety, depression, cancer cell growth and much more.
Research continues at Medical Marijuana Genetics to create strains that contain highly beneficial amounts of other cannabinoids and terpenoids.
For the time being, all of the strains available from Medical Marijuana Genetics are CBD dominant or CBD rich (At least 1:1) and all strains contain a minimum of 10 % CBD.
Medical Marijuana Genetics are one of a growing number of seedbanks that encourage customers, who are legally permitted to grow, to publish laboratory results of the cannabis they have produced.
Candida (CD-1) and a further five strains have been specifically created for medical use are available now.